Administration of Ovalbumin Encapsulated in Alginate Microspheres to Mice

T. L. Bowersock, H. Hogenesch, M. Suckow, John Turek, E. Davis-Snyder, D. Borie, R. Jackson, Haesun Park, Kinam Park

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Sodium alginate microparticles were tested as a delivery system for oral vaccines. Ovalbumin was incorporated into alginate microparticles. The release of ovalbumin from the microparticles was determined. Electron microscopy was performed to evaluate surface characteristics of the microparticles. Plain microspheres or ovalbumin incorporated within alginate microspheres were administered orally to groups of mice; another 2 groups were given either ovalbumin in microspheres or in Freund's adjuvant by subcutaneous injection. Antibodies specific to ovalbumin were measured in serum and antibody-secreting cells specific for ovalbumin were enumerated in spleen cells. Microparticles released ovalbumin within 5 days in vitro. Alginate microparticles were uniform in density and spherical in shape by electron microscopy. Mice had increased numbers of antibody secreting cells and serum antibody titers specific for ovalbumin regardless of the method of inoculation. These studies suggest that alginate microparticles could be used for the delivery of antigens. Further studies of this delivery system are warranted.

Original languageEnglish (US)
Pages (from-to)58-66
Number of pages9
JournalACS Symposium Series
Volume627
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'Administration of Ovalbumin Encapsulated in Alginate Microspheres to Mice'. Together they form a unique fingerprint.

Cite this